Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$8.3M Sell
34,145
-5,140
-13% -$1.17M 0.13% 278
2017
Q3
$7.94M Sell
39,285
-35,540
-47% -$6.99M 0.14% 245
2017
Q2
$15.3M Buy
74,825
+19,420
+35% +$3.87M 0.33% 24
2017
Q1
$10.1M Buy
55,405
+35,718
+181% +$6.23M 0.22% 114
2016
Q4
$3.16M Sell
19,687
-7,176
-27% -$1.05M 0.1% 386
2016
Q3
$3.79M Sell
26,863
-9,190
-25% -$1.28M 0.14% 227
2016
Q2
$4.91M Buy
36,053
+29,897
+486% +$3.97M 0.27% 85
2016
Q1
$834K Sell
6,156
-21,935
-78% -$2.96M 0.05% 440
2015
Q4
$4.21M Buy
28,091
+14,330
+104% +$2.12M 0.33% 110
2015
Q3
$1.84M Sell
13,761
-57,242
-81% -$8.01M 0.29% 92
2015
Q2
$9.31M Buy
71,003
+9,438
+15% +$1.17M 0.37% 12
2015
Q1
$7.35M Buy
61,565
+25,654
+71% +$2.85M 0.29% 35
2014
Q4
$3.79M Sell
35,911
-17,149
-32% -$1.81M 0.2% 169
2014
Q3
$5.46M Buy
+53,060
New +$5.38M 0.42% 35

Other funds holding CHE

AHL Partners's CHE Position: Q4 2017 in Review

AHL Partners reduced its Chemed (CHE) stake by 13% in Q4 2017, selling an estimated $1.17M and leaving 34,145 shares worth $8.3M. The position accounts for 0.13% of the portfolio, ranked #278.

AHL Partners first reported a position in CHE in Q3 2014 and has held it in 14 quarters since. The position peaked at $15.3M in Q2 2017. 299 funds tracked by Wall St. Rank hold CHE as of Q4 2017.

  • AHL Partners held 34,145 shares of Chemed worth $8.3M as of Q4 2017.
  • AHL Partners sold 5,140 Chemed shares in Q4 2017, an estimated $1.17M.
  • Chemed made up 0.13% of AHL Partners's portfolio in Q4 2017, its #278 holding.
  • AHL Partners first reported a position in Chemed in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Chemed position peaked at $15.3M in Q2 2017.
  • 299 funds tracked by Wall St. Rank held Chemed as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.